Clinical Trial

Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Acne vulgaris is the most common skin condition affecting late adolescents worldwide.1 The prevalence of acne is said to be 85% in adults aged 12 to 25 years.2 Almost all teenagers between 15 and 17 years report having some degree of acne.3 Estimates of the lifetime occurrence of acne in the literature range from 0.1%4 to as high as 85.1%5 in the general population, depending on the age range, region, and method of sampling. Overall, acne is more common in women,8,9 but in some literature the prevalence is approximately equal in men and women.10,11
Trial Details
NCT Number NCT07062081
Lead Sponsor Sohag University
Conditions Acne Vulgaris
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-14